Table 2.
Statistics of the TCGA dataset
| Cancer | Number of omics features | Number of samples for each clinical feature | ||||||
|---|---|---|---|---|---|---|---|---|
| GE | ME | MI | CNV | Subtype | Pathologic-stage | Gender | Age | |
| BLCA | 17390 | 396065 | 2195 | 21933 | 1 (41) | StageII (128) | MALE (296) | Middle (124) |
| 2 (41) | StageIII (136) | FEMALE (104) | Old (244) | |||||
| 3 (29) | StageIV (132) | Total (400) | Total (368) | |||||
| 4 (15) | Total (396) | |||||||
| Total (126) | ||||||||
| BRCA | 2222 | LumA (323) | StageI (96) | - | Young (16) | |||
| LumB (118) | StageII (345) | Middle (221) | ||||||
| Basal (102) | StageIII (151) | Old (81) | ||||||
| Her2 (39) | Total (592) | Total (318) | ||||||
| Total (582) | ||||||||
| COAD | 2097 | CMS1 (34) | StageI (36) | MALE (137) | Middle (99) | |||
| CMS2 (67) | StageII (83) | FEMALE (112) | Old (130) | |||||
| CMS3 (35) | StageIII (67) | Total (249) | Total (229) | |||||
| CMS4 (63) | StageIV (29) | |||||||
| Total (199) | Total (215) | |||||||
| HNSC | 2229 | Basal (74) | StageI (26) | MALE (347) | Middle (261) | |||
| Mesenchymal (65) | StageII (71) | FEMALE (124) | Old (168) | |||||
| Atypical (59) | StageIII (74) | Total (471) | Total (429) | |||||
| Classical (44) | StageIV (234) | |||||||
| Total (242) | Total (405) | |||||||
| KIRP | 2099 | C1 (84) | StageI (164) | MALE (200) | Middle (141) | |||
| C2a (34) | StageII (18) | FEMALE (68) | Old (91) | |||||
| C2b (21) | StageIII (49) | Total (268) | Total (232) | |||||
| Total (139) | StageIV (14) | |||||||
| Total (245) | ||||||||
| LIHC | 2157 | 1 (65) | StageI (166) | MALE (243) | Middle (171) | |||
| 2 (55) | StageII (84) | FEMALE (114) | Old (129) | |||||
| 3 (63) | StageIII (61) | Total (357) | Total (300) | |||||
| Total (183) | Total (311) | |||||||
| LUAD | 2211 | 1 (17) | StageI (233) | MALE (205) | Middle (174) | |||
| 2 (22) | StageII (108) | FEMALE (237) | Old (212) | |||||
| 3 (38) | StageIII (62) | Total (442) | Total (386) | |||||
| 4 (26) | StageIV (19) | |||||||
| 5 (43) | Total (422) | |||||||
| 6 (33) | ||||||||
| Total (179) | ||||||||
| SKCM | 2203 | BRAF (116) | StageI (72) | MALE (220) | Middle (175) | |||
| RAS (78) | StageII (67) | FEMALE (130) | Old (103) | |||||
| TWT (37) | StageIII (137) | Total (350) | Young (29) | |||||
| NF1 (23) | StageIV (20) | Total (307) | ||||||
| Total (254) | Total (296) | |||||||
| STAD | 2161 | CIN (202) | StageI (46) | MALE (240) | Old (177) | |||
| MSI (59) | StageII (116) | FEMALE (125) | Middle (133) | |||||
| GS (46) | StageIII (163) | Total (365) | Total (310) | |||||
| EBV (29) | StageIV (28) | |||||||
| Total (336) | Total (353) | |||||||
| THCA | 2201 | 1 (131) | StageI (279) | MALE (133) | Middle (237) | |||
| 2 (67) | StageII (50) | FEMALE (361) | Young (166) | |||||
| 3 (82) | StageIII (109) | Total (494) | Old (45) | |||||
| 4 (105) | StageIV (46) | Total (448) | ||||||
| 5 (90) | Total (484) | |||||||
| Total (475) | ||||||||